![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Menta E. Palumbo M.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.8, Iss.12, 1998-12, pp. : 1627-1672
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Toxicities of the platinum antineoplastic agents
Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 12, 1997-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 12, 1998-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design, Vol. 14, Iss. 27, 2008-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intrathecal Chemotherapy With Antineoplastic Agents in Children
By Ruggiero A.
Pediatric Drugs, Vol. 3, Iss. 4, 2001-01 ,pp. :